About the Authors

  • The Authors and Contributors of "Patent Docs" are patent attorneys and agents, many of whom hold doctorates in a diverse array of disciplines.
2018 Juristant Badge - MBHB_165
Juristat #4 Overall Rank

E-mail Newsletter

  • Enter your e-mail address below to receive the "Patent Docs" e-mail newsletter.

Enter your email address:

Delivered by FeedBurner

Contact the Docs

Docs on Twitter


Disclaimer

  • "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat_165
Juristat #8 Overall Rank

Pharma-50-transparent_216px_red

« Athena Diagnostics v. Mayo Collaborative Services -- The Dissents | Main | IPW Webinar on § 112 »

July 18, 2019

Comments

Oh, that's the ticket: ex post facto, let's go after every pharma company that, years after grant, had a patent declared invalid as obvious, by arguing that the subsequent invalidation proves the patent should never have been granted and thus was obtained through inequitable conduct; and that, further, to the extent the patentee's market position was improved as a result of the patent, and the patentee was reimbursed by medicare, the patentee made false claims against the federal government.

Yeah, that's a winning strategy for encouraging investment in new drugs. And it includes a good dose of intellectual dishonesty too. But it succeeds in one sense: if there are no new drugs, then eventually prices on the existing drugs will fall.

Of course, the FDA's own practices, and complicated medicare reimbursement formulae, have *nothing* do with high drug prices. No sir, no at all.

The comments to this entry are closed.

November 2019

Sun Mon Tue Wed Thu Fri Sat
          1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30